Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/25/2003WO2002082086A3 Detection of methicillin-resistant staphylococcus aureus (mrsa)
09/25/2003WO2002077277B1 Dna markers for assessing seed purity and a method of using dna sequences for assessing seed purity
09/25/2003WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
09/25/2003WO2002076482A3 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
09/25/2003WO2002072889A3 Methods and compositions for microarray control
09/25/2003WO2002072880A3 Method for detecting cytosine methylation patterns having high sensitivity
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002063048A3 Methods for predicting sensitivity of tumors to arginine deprivation
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression
09/25/2003WO2002059379A3 Methods for detecting, grading or monitoring an $i(h. pylori) infection
09/25/2003WO2002055736A3 Antisense imaging of gene expression of the brain in vivo
09/25/2003WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
09/25/2003WO2002044422A3 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
09/25/2003WO2002038792A3 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
09/25/2003WO2002031203A3 High throughput or capillary-based screening for a bioactivity or biomolecule
09/25/2003WO2002031146A3 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
09/25/2003WO2002030964A3 Comparative ligand mapping from mhc positive cells
09/25/2003WO2002029110A3 Efficient tests of association for quantitative traits and affected-unaffected studies using pooled dna
09/25/2003WO2002029101A3 Methods for cloning, sequencing and expressing genes from complex microbial populations
09/25/2003WO2002027029A3 Method for determining relative abundance of nucleic acid sequences
09/25/2003WO2002026982A3 Secreted human proteins
09/25/2003WO2002024910A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/25/2003WO2002023187A3 Facile detection of cancer and cancer risk based on level of coordination between alleles
09/25/2003WO2002022889A3 Direct haplotyping using carbon nanotube probes
09/25/2003WO2002022874A3 Oligonucleotides for labeling oligonucleotide probes and proteins
09/25/2003WO2002020846A3 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
09/25/2003WO2002020754A3 Molecules for diagnostics and therapeutics
09/25/2003WO2002018661A3 Methods for identifying novel therapeutic agents
09/25/2003WO2002014368A3 Proteins and nucleic acids encoding the same
09/25/2003WO2002014361A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
09/25/2003WO2002012561A3 Haplotypes of the or1g1 gene
09/25/2003WO2002010457A3 Targeting of dna sequences by the use of recombinase coated dna probes
09/25/2003WO2002010455A3 Methods for identifying genomic deletions
09/25/2003WO2002008425A3 Haplotypes of the adrb3 gene
09/25/2003WO2002004661A3 Methods for classifying nucleic acids and polypeptides
09/25/2003US20030182674 Method of making a genetically modified mammal
09/25/2003US20030182670 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
09/25/2003US20030182667 Type iii allergic inflammation model animal
09/25/2003US20030181826 Hydrophobic/hydrophilic sample collection tip
09/25/2003US20030181710 Death domain-containing receptor polynucleotides, polypeptides, and antibodies
09/25/2003US20030181706 Inflammation-associated polynucleotides
09/25/2003US20030181693 Increased nuclease resistance, enhanced binding affinity and improved protein binding; side effect reduction
09/25/2003US20030181663 Human stanniocalcin-alpha
09/25/2003US20030181661 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
09/25/2003US20030181659 Thrombopoietin receptor modulating peptide
09/25/2003US20030181658 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers
09/25/2003US20030181480 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds
09/25/2003US20030181423 Latent reactive polymers with biologically active moieties
09/25/2003US20030181412 Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
09/25/2003US20030181407 Steatosis-modulating factors and uses thereof
09/25/2003US20030181379 Novel fibroblast growth factor (FGF23) and methods for use
09/25/2003US20030181364 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions.
09/25/2003US20030181355 Inhibiting viral morphogenesis and viral infection. In particular, it concerns effecting such inhibition by inhibiting the prenylation or post prenylation reactions of a viral or host protein.
09/25/2003US20030180953 Gene disruption methodologies for drug target discovery
09/25/2003US20030180931 Cellubrevin homologs
09/25/2003US20030180923 An amino acid sequence free of its associated signal peptide; fusion proteins, host cell of an E. coli or a yeast cell, immunomodulator, immunostimulants, cell proliferation, tumor detection, receptor binding assay
09/25/2003US20030180894 Oligonucleotides and method for characterizing and detecting Genogroup II type small round structured virus
09/25/2003US20030180887 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/25/2003US20030180883 Human tumor necrosis factor receptor TR10
09/25/2003US20030180881 PRO polypeptides; fusion proteins; immunoglobulins
09/25/2003US20030180880 Chromosome 1 gene and gene products related to alzheimer's disease
09/25/2003US20030180879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180878 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180876 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180875 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180874 PRO polypeptides; fusion proteins; immunoglobulins; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells; for stimulating release of proteoglycans from cartilage
09/25/2003US20030180873 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180871 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
09/25/2003US20030180870 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
09/25/2003US20030180868 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180866 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage
09/25/2003US20030180865 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180864 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030180832 Expressing an uncoupled ATPase activity in a specific cell to induce conversion of ATP to ADP without primary effects on the cellular metabolites or functions, and incubating the cell with a suitable substrate to prodcue the biomass
09/25/2003US20030180831 Microbe suspension is poured into each of the electrolytic cells at a position which is in vicinity to the electrode for measurement of dissolved oxygen concentration, and current from each electrode for oxygen is measured
09/25/2003US20030180830 Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway
09/25/2003US20030180829 Methods for the identification of inhibitors of homocitrate synthase as antibiotics
09/25/2003US20030180828 Providing a biological sample of a patient susceptible to developing angioedema, determining a dipeptidyl peptidase IV activity in the sample and comparing enzyme activity to a standard dipeptidyl peptidase IV activity
09/25/2003US20030180827 Highly sensitive and continuous protein tyrosine phosphatase test using 6,8-difluoro-4-methylumbelliferyl phosphate
09/25/2003US20030180826 Method and test kit for detecting cockroach allergens and determining total allergen level
09/25/2003US20030180824 System for performing blood coagulation assays and measuring blood clotting times
09/25/2003US20030180823 Use of metabolic phenotyping
09/25/2003US20030180821 Identifying an agent that bind gene products critical for the survival of microbes, such as staphylococcus microbe, and that interfere with the expression of such gene products
09/25/2003US20030180818 Isolated nucleic acid molecules encoding human peptidoglycan recognition protein-related proteins, referred to PGRP-K (keratinocytes), PGRP-W (wound healing) and PGRP-C (chondrosarcoma)
09/25/2003US20030180817 Determining levels of a colon specific gene in the cells, or bodily fluids in a patient, comparing determined levels of CSG with levels of CSG in cells from normal human control, wherein a change in level of CSG indicates presence of cancer
09/25/2003US20030180814 Direct immunosensor assay
09/25/2003US20030180810 For diagnosis, prevention, and treatment of reproductive disorders, Alzheimer's disease, cancer, immunological disorders, and diabetes
09/25/2003US20030180808 Drug signatures
09/25/2003US20030180807 Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof
09/25/2003US20030180805 Methods and compositions for derepression of IAP-inhibited caspase
09/25/2003US20030180798 Analyzing second messenger sigalling activity; drug screening
09/25/2003US20030180797 Identification of ligands for a receptor family and related methods
09/25/2003US20030180790 Testing nucleobase affinity via applying voltage to sequences and evaluating; homologous recombination
09/25/2003US20030180789 Arrays with modified oligonucleotide and polynucleotide compositions
09/25/2003US20030180786 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/25/2003US20030180783 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/25/2003US20030180782 Comprises pipetting robot or voltage-driven fluidic transport for hybridization
09/25/2003US20030180781 High speed hybridization of oligonucleotides with polymerases/exonucleases
1 ... 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 ... 3003